AstraZeneca, a pioneer in the progression of a vaccine against the coronavirus, suspended clinical trials on Tuesday after a suspected serious adverse reaction in a player from the United Kingdom, The New York Times reported.
According to Stat News, a fitness news website, AstraZeneca said in a statement that “the company’s popular review procedure has caused a pause in vaccination to allow review of protection data. “
JUST IN: AstraZeneca vaccine trial paused to investigate “a potentially unexplained illness” https://t.co/HG6EdHBcU5 pic.twitter.com/XtESK999Gc
“This is a regimen action that deserves to take place whenever there is an unexplained illness in any of the trials, while investigating, ensuring that we maintain the integrity of the testing,” the company said. “In giant trials, illnesses occur by chance, but they need to be examined independently to check this carefully. We are working to speed up the review of the single occasion to minimize any possible effect on the testing schedule. “
AstraZeneca is one of 3 corporations that have Phase 3 COVID-19 vaccine trials underway in the United States, according to The Hill. Other corporations that are conducting trials for potential vaccines include Pfizer and Moderna, it reported.
It is not transparent whether AstraZeneca or a regulator stopped the lawsuit, Stat News reported. The patient recovers, according to the website.
The COVID-19 vaccine is a progression through researchers from AstraZeneca and the University of Oxford at 62 sites in the United States, as well as sites in the United Kingdom, Stats News reported.
© 2020 Cox Media Group